Anne Stern
29Patents
9h-index
38Co-inventors
75Inventor score
Filing activity: May 31, 1990 → May 15, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7563441B2 | Anti-P-selectin antibodies | Emerging Cross-Sectional Technologies | 64 | Expired |
| US8771988B2 | Protein expression from multiple nucleic acids | Chemistry; Metallurgy | 30 | Active |
| US6391633B1 | Production of erythropoietin by endogenous gene activation | Chemistry; Metallurgy | 28 | Expired |
| US5162199A | Neisseria-specific DNA probe | Emerging Cross-Sectional Technologies | 14 | Expired |
| US7824684B2 | Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies | Emerging Cross-Sectional Technologies | 11 | Active |
| US5378606A | Specific detection of Neisseria gonorrhoeae | Chemistry; Metallurgy | 11 | Expired |
| US7008764B1 | Optimization of cells for endogenous gene activation | Chemistry; Metallurgy | 11 | Expired |
| US5223256A | Thrombolytically active non-glycosylated protein | Human Necessities | 10 | Expired |
| US5173401A | Detection of Neisseria gonorrohoeae | Chemistry; Metallurgy | 10 | Expired |
| US6544748B2 | Preparation of erythropoietin by endogenous gene activation | Chemistry; Metallurgy | 7 | Expired |
| US7214532B2 | Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof | Chemistry; Metallurgy | 6 | Expired |
| US7754867B2 | Nucleic acid molecules encoding anti-P-selectin antibodies | Emerging Cross-Sectional Technologies | 6 | Active |
| US9329985B1 | Using emulation to disassociate verification from stimulus in functional test | Physics | 4 | Active |
| US6548296B1 | Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof | Chemistry; Metallurgy | 4 | Expired |
| US6555373B1 | Methods for identifying human cell lines useful for endogenous gene activation isolated human cell lines identified thereby, and uses thereof | Chemistry; Metallurgy | 3 | Expired |
| US7186529B2 | Preparation of erythropoietin by endogenous gene activation | Chemistry; Metallurgy | 2 | Expired |
| US6225094A | Method for the genus-specific or/and species-specific detection of bacteria in a sample liquid | Chemistry; Metallurgy | 2 | Expired |
| USRE43568E1 | Anti-P-selectin antibodies | General | 2 | Active |
| US10489274B2 | Using emulation to disassociate verification from stimulus in functional test | Physics | 2 | Active |
| US5223422A | t-PA mutant GK1L | Human Necessities | 1 | Expired |
| US5973118A | Mutant of the Erythrina caffra type inhibitor and the use of the said mutant for purifying serine proteases | Chemistry; Metallurgy | 1 | Expired |
| US5723122A | Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases | Human Necessities | 1 | Expired |
| US5908625A | Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases | Human Necessities | 1 | Expired |
| US9971672B2 | Using emulation to disassociate verification from stimulus in functional test | Physics | 1 | Active |
| USRE44389E1 | Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies | General | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.